Midazolam In Sodium Chloride Injection, Solution
Product Images NDC 65219-650

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Midazolam In Sodium Chloride (NDC 65219-650). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Midazolam-structure (Mid0i 0000 01)

Chemical structure diagram of the active ingredient Midazolam, showing its molecular components including a chlorinated benzodiazepine ring and fluorine-substituted phenyl group.*

FDA Label Image

Fresenius Kabi Logo (Mid0i 0000 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Midazolam in 0.9% Sodium Chloride Injection Bag Label)

Label for Midazolam in 0.9% Sodium Chloride Injection, 1 mg/mL concentration, 50 mg per 50 mL single-dose solution for intravenous use. The label indicates it is a high alert medication, manufactured for Fresenius Kabi USA, LLC, and includes storage instructions and warnings such as not diluting or adding supplementary medication.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Midazolam in 0.9% Sodium Chloride Injection Overpouch Label)

Label for Midazolam in 0.9% Sodium Chloride Injection 1 mg/mL in a 50 mL single-dose container. The intravenous solution is marked as a high alert medication and should not be diluted. Manufactured by Fresenius Kabi USA, LLC, the label includes storage instructions and cautions regarding use and handling.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Midazolam in 0.9% Sodium Chloride Injection Carton Label)

Midazolam in 0.9% Sodium Chloride Injection 50 mg per 50 mL (1 mg per mL) intravenous injection solution. The label states it is for intravenous use only, not to dilute, and contains 10 single-dose bags. Manufactured for Fresenius Kabi USA, LLC with storage instructions and cautionary notes for single-dose containers.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Midazolam in 0.9% Sodium Chloride Injection Bag Label)

Label of Midazolam in 0.9% Sodium Chloride Injection, 1 mg/mL (100 mg per 100 mL) for intravenous use. The label indicates it is a high alert medication in a 100 mL single-dose container, manufactured for Fresenius Kabi USA, LLC. Storage instructions and usage warnings are included.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Midazolam in 0.9% Sodium Chloride Injection Overpouch Label)

Label for Midazolam in 0.9% Sodium Chloride Injection 1 mg/mL solution, 100 mg per 100 mL (100 mL total), for intravenous use. Highlights it as a High Alert Medication with instructions to not dilute. Manufactured for Fresenius Kabi USA, LLC, Lake Zurich, IL, and made in India. Includes storage and usage precautions and a barcode.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Midazolam in 0.9% Sodium Chloride Injection Carton Label)

Label for Midazolam in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg/mL) intravenous solution. The label indicates the product is for intravenous use only, should not be diluted, and is packaged as 10 single-dose bags. The labeler is Fresenius Kabi USA, LLC, with manufacturing done in India. The NDC is 65219-650-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.